Cellectis S.A.
CLLS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001627281
No open-market purchases or sales by Cellectis S.A. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $28.4M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Cellectis S.A. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q2 2025
- Shares held
- 8.31M
- −3.45M (−29.3%) vs. Q2 2025
- Total value
- $23.7M
- +$5.83M (+32.7%) vs. Q2 2025
- New holders
- 7
- 6 more added
- Sold out
- 3
- 6 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $28.4M |
| Q1 2026 | 32 | $32.5M |
| Q4 2025 | 34 | $51.1M |
| Q3 2025 | 28 | $23.7M |
| Q2 2025 | 24 | $17.9M |
| Q1 2025 | 27 | $16.9M |
| Q4 2024 | 29 | $23.0M |
| Q3 2024 | 27 | $20.9M |
| Q2 2024 | 27 | $18.3M |
| Q1 2024 | 31 | $26.1M |
| Q4 2023 | 34 | $30.2M |
| Q3 2023 | 31 | $18.1M |
| Q2 2023 | 36 | $27.6M |
| Q1 2023 | 34 | $29.3M |
| Q4 2022 | 40 | $18.3M |
| Q3 2022 | 50 | $23.6M |
| Q2 2022 | 45 | $30.6M |
| Q1 2022 | 51 | $55.8M |
| Q4 2021 | 57 | $123.7M |
| Q3 2021 | 70 | $194.1M |
| Q2 2021 | 78 | $250.6M |
| Q1 2021 | 81 | $308.0M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Cellectis S.A.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Long Focus Capital Management, LLC | 4,123,262 | $11.8M | 0.67% | −594,031−12.6% | Reduced |
| B Group, Inc. | 3,281,501 | $9.35M | 8.94% | +25,000+0.8% | Added |
| Macquarie Group Ltd | 226,875 | $647.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 221,959 | $632.6K | 0.00% | +221,959 | New |
| Morgan Stanley | 87,675 | $249.9K | 0.00% | −5,120−5.5% | Reduced |
| LPL Financial LLC | 85,147 | $242.7K | 0.00% | −515−0.6% | Reduced |
| Millennium Management LLC | 57,740 | $164.6K | 0.00% | +22,080+61.9% | Added |
| Susquehanna International Group, LLP | 53,865 | $153.5K | 0.00% | +19,432+56.4% | Added |
| BNP Paribas Arbitrage, SA | 41,300 | $117.7K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 29,299 | $83.5K | 0.00% | +3,670+14.3% | Added |
| Virtu Financial LLC | 25,211 | $72.0K | 0.00% | +25,211 | New |
| Delaney Dennis R | 24,000 | $68.4K | 0.03% | +24,000 | New |
| Baird Financial Group, Inc. | 11,090 | $31.6K | 0.00% | +11,090 | New |
| Marshall Wace, LLP | 10,435 | $29.7K | 0.00% | +10,435 | New |
| First Affirmative Financial Network | 10,149 | $28.9K | 0.01% | −9,636−48.7% | Reduced |
| JPMorgan Chase & Co | 4,945 | $14.1K | 0.00% | +3,168+178.3% | Added |
| Harbour Investments, Inc. | 4,500 | $12.8K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 3,600 | $10.1K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 3,150 | $8.98K | 0.00% | −14,000−81.6% | Reduced |
| Atlantic Union Bankshares Corp | 1,500 | $4.28K | 0.00% | +1,500 | New |
| Rhumbline Advisers | 1,455 | $4.15K | 0.00% | −450−23.6% | Reduced |
| Citigroup Inc | 990 | $2.82K | 0.00% | +990 | New |
| Allworth Financial LP | 500 | $1.43K | 0.00% | 00.0% | Unchanged |
| POM Investment Strategies, LLC | 495 | $1.41K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 196 | $559 | 0.00% | +183+1,407.7% | Added |
| Principal Securities, Inc. | 179 | $510 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 100 | $285 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 77 | $220 | 0.00% | 00.0% | Unchanged |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −3,178,620−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −11,747−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,132−100.0% | Sold out |